C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
167/130, 167/140
C12N 9/76 (2006.01) A61K 39/21 (2006.01) A61K 39/42 (2006.01) C07K 16/40 (2006.01) C12N 9/64 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2025630
ABSTRACT OF THE DISCLOSURE Novel human tryptase-like protein having both trypsin-like and chymotrypsin-like activity specifically binds with anti-rat tryptase antibody and comprises two subunits of about 35+3 KDa and four subunits of about 30+2 KDa. The human tryptase-like protein can be obtained from human acute lymphoblastic leukemia cell line, Molt 4. The anti-human tryptase-like protein antibody strongly inhibits HIV infection, which is indicated by a potent inhibition of syncytia formation. Pharmaceutical compositions comprising the anti-human tryptase-like protein antibody are effective for the treatment of AIDS.
Katunuma Nobuhiko
Yoshimoto Makoto
Fetherstonhaugh & Co.
Katunuma Nobuhiko
Taisho Pharmaceutical Co. Ltd.
Yoshimoto Makoto
LandOfFree
Human tryptase-like protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human tryptase-like protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human tryptase-like protein will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1400501